Michael W.P. Soeryadjaya, an Indonesian citizen, has served as the Company’s President Director since 10 June 2015 and was reappointed for the 2022-2025 period by the AGMS on 21 April 2022. He also chairs the Company’s Investment Committee of the Company. He is affiliated with Edwin Soeryadjaya, the President Commissioner and one of the Company’s main shareholders.

Michael is a seasoned professional in merger and acquisitions, with a strong track record in investment strategy. His expertise has contributed to the success of several Initial Public Offerings, including those of the Company, PT Mitra Pinasthika Mustika Tbk and PT Merdeka Copper Gold Tbk. He has played a pivotal role in overseeing investments, including PT Mulia Bosco Logistik, PT Zulu Alpha Papa (ZAP), and PT Brawijaya Investama (Brawijaya Hospital).

He previously served as a Director of PT Alamtri Resources Indonesia Tbk (formerly PT Adaro Energy Indonesia Tbk) until June 2025. He currently serves as a Commissioner of PT Samator Indo Gas Tbk since July 2022, PT Merdeka Battery Materials Tbk since January 2023, and PT Alamtri Minerals Indonesia Tbk (formerly PT Adaro Minerals Indonesia Tbk) since June 2025.

Michael earned a Bachelor of Arts degree in Business Administration from Pepperdine University, USA.

Lany Djuwita Wong, an Indonesian citizen, has been serving as Company’s Finance Director since 26 June 2018 and was reappointed in 2019 and 2022. She is also a Commissioner of the Indonesia Stock Exchange as of June 2024 and Director of PT Alamtri Resources Indonesia Tbk (formerly PT Adaro Energy Indonesia Tbk) since June 2025. She is not affiliated with the Company’s main shareholders, Commissioners, or other Directors.

Prior to joining the Company, she was Director and Chief Financial Officer of PT Dharma Satya Nusantara Tbk (2016-2018) and PT Medco Energi Internasional Tbk (2013-2015). During her tenure at Medco, which began in 2006, she held several key positions, including Director of subsidiaries, Head of Corporate Finance and Head of Corporate Planning and Performance. She previously held roles at Arthur Andersen, Astra International, and PricewaterhouseCoopers where she served as Manager of Financial Advisory Services.

Lany holds a Bachelor’s degree in Economics (Accounting) from Universitas Indonesia (1993) and a Master’s degree in Finance from Texas A&M University, USA (1996). She is a Chartered Financial Analyst Charterholder.

Devin Wirawan, an Indonesian citizen, has been the Company’s Investment Director since 22 May 2019, with reappointment in 2022. He holds a bachelor’s degree in Finance and Management Information Systems from Curtis L. Carlson School of Management, the University of Minnesota, Twin Cities, Minnesota, USA. He is not affiliated with the Company’s main shareholders, Commissioners, or other Directors.

Devin began his career as a Strategy and Trading Analyst with University Capital Strategies Group in Saint Paul, USA, before joining Titan Capital in Singapore. He later returned to University Capital Strategies Group in Singapore as a Senior Strategy and Trading Analyst before joining Saratoga in 2009.

Throughout his tenure at Saratoga, Devin has held key strategic roles, including serving as the Executive Committee of PT Medco Power Indonesia (until 2017), Director of PT Paiton Energy (until 2018), Executive Committee member of PT Deltomed Laboratories (until January 2024), and Director of Xurya Pte. Ltd. (2022 until May 2025). Currently, he serves as CEO of Brawijaya Hospital.